The Journal of Community and Supportive OncologyPancreatitis associated with newer classes of antineoplastic therapiesJuly 25, 2017Patient & Survivor CareImmunotherapy
Hospital Physician: Hematology/OncologyTargeted Therapy and Immunotherapy in the Treatment of Metastatic Cutaneous MelanomaJuly 1, 2017ImmunotherapyMelanoma
Oncology PracticeVIDEO: Cancer immunotherapies activate rheumatologic adverse effectsJune 27, 2017Immunotherapy
Hematology NewsPembrolizumab + rituximab boost response rates in relapsed follicular lymphomaJune 26, 2017Indolent LymphomaImmunotherapyLymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticeStudies provide insight into link between cancer immunotherapy and autoimmune diseaseJune 15, 2017Immunotherapy
Oncology PracticeVIDEO: Immune therapy effective, durable in treatment-naive melanoma brain metastasesJune 12, 2017MelanomaImmuno-oncologyImmunotherapyCNS/Brain Cancer
Oncology PracticeVIDEO: Combined immunotherapy strategy shows promise in advanced solid tumorsJune 6, 2017Immuno-oncologyImmunotherapy
Oncology PracticeImmune-agonist combo has activity against several tumor typesJune 5, 2017Immuno-oncologyImmunotherapyBreast CancerMelanomaRenal Cell CarcinomaGynecologic CancerGenitourinary Cancer
The Journal of Community and Supportive OncologyPalmoplantar exacerbation of psoriasis after nivolumab for lung cancerMay 17, 2017Lung CancerPatient & Survivor CareImmunotherapy
Oncology PracticeFDA approves pembrolizumab for first-line advanced NSCLCMay 12, 2017Lung CancerImmunotherapyImmuno-oncology
Oncology PracticeFlu shots may spark immune adverse events in PD-1 blockade for NSCLCMay 7, 2017ImmunotherapyLung CancerImmuno-oncology
Oncology PracticeModifying CAR-T with IL-15 improved activity in glioma modelsApril 27, 2017CNS/Brain CancerPediatricsImmunotherapy
Hematology NewsVIDEO: Blinatumomab, inotuzumab reshape relapsed ALL treatmentApril 9, 2017ALLImmunotherapyLeukemia, Myelodysplasia, Transplantation
Oncology PracticeAtezolizumab improved survival in triple-negative breast cancerApril 8, 2017Breast CancerImmunotherapy
Oncology PracticeGet ready for cancer immunotherapy-induced rheumatic diseasesApril 3, 2017ImmunotherapyMelanomaMultiple MyelomaImmuno-oncology
